AMY WERTMAN: Open Payments
NPI 1669470738 · BRYN MAWR, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$892 in 34 payments from 16 companies in 2025. Trend: 2023 $634 · 2024 $541 · 2025 $892
Food & beverage: $892
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $209 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $113 |
| ABBVIE INC. | 5 | $100 |
| UROGEN PHARMA, INC. | 3 | $77 |
| Novartis Pharmaceuticals Corporation | 4 | $67 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $60 |
| BIOPROTECT MEDICAL, INC. | 1 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
| IMMUNITYBIO, INC. | 2 | $47 |
| Merck Sharp & Dohme LLC | 1 | $28 |
Products named: ERLEADA, BOTOX, Nubeqa, PLUVICTO, PYLARIFY, BIOPROTECT BALLOON IMPLANT SYSTEM, GEMTESA, ANKTIVA.
Industry payments across PA — which companies pay providers there.
